Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Cantor Fitzgerald Downgrades NetApp (NTAP) to Hold
-
Cantor Fitzgerald Upgrades Salix Pharmaceuticals (SLXP) to Buy
-
Cantor Fitzgerald Downgrades Echelon (ELON) to Hold
-
Cantor CEO "Not Sure" If They'll Buy Knight Capital (KCG)
-
Cantor Fitzgerald Downgrades Obagi Medical Products (OMPI) to Hold; Slowing Growth and Speculation
-
Cantor Fitzgerald Upgrades First Solar (FSLR) to Buy; Raising Estimates on Stronger Pipeline
-
Cantor Fitzgerald Downgrades Salix Pharmaceuticals (SLXP) to Hold; Relistor Receives Complete Response Letter
-
Cantor Fitzgerald Downgrades Varian Medical (VAR) to Hold: Headwinds Mounting
-
Q3 Preview: Whole Foods (WFM): Down, But Definitely Not Out
-
Cantor Fitzgerald Maintains a 'Buy' on Ligand Pharma (LGND); Key Partnered Drug is Approved
-
Cantor Fitzgerald Upgrades Cypress Semi (CY) to Hold; In-Line Q2, Disappointing Outlook, But Downside Limited
-
Cantor Fitzgerald on Intuitive Surgical (ISRG): Good Q2, But Shares Are Priced For Perfection
-
Cantor Fitzgerald Reiterates a 'Buy' on Wynn Resorts (WYNN); No Lady Luck, But Thesis Remains Intact
-
Cantor Fitzgerald Defends SUPERVALU (SVU); Disappointing Results, But There Are Some Positives
-
Cantor Fitzgerald Starts Bruker (BRKR) at Buy
-
Q2 Preview: Marriott (MAR) to Kick-Off Earnings Season for Lodging Group
-
Notable Analyst Rating Changes 07/10: (LUV) (BMR) (CE) Upgraded; (FST) (LPX) (TSN) Downgraded
-
Cantor Fitzgerald Downgrades DuPont Fabros Technology (DFT) to Hold; Less Data Needed
-
Cantor Fitzgerald Upgrades BioMed Realty (BMR) to Buy; Growing Demand...For Labs
-
Cantor Fitzgerald Starts Las Vegas Sands (LVS) at Buy; Dominant Global Player with Significant Assets
-
Cantor Fitzgerald Starts MGM Resorts (MGM) at Buy; Continued Deleveraging; Las Vegas Bouncing Back
-
Cantor Fitzgerald Starts Wynn Resorts (WYNN) at Buy; Recent Correction Offers Good Entry Point
-
Analyst Says Obagi (OMPI) Could Soon See Offers from 'Multiple Suitors'
-
Cantor Fitzgerald Downgrades Cousins Properties (CUZ) to Sell; Look For Better Entry Point
-
Cantor Fitzgerald Upgrades UDR, Inc. (UDR) to Hold; Redefined its Footprint
-
Notable Analyst Rating Changes 06/28: (OREX) (HAL) (DRIV) Upgraded; (WFT) (MTL) (CBE) Downgraded
-
Cantor Fitzgerald Starts Broadcom (BRCM) at Buy; Everything Goes Through Me First
-
Cantor Fitzgerald Starts Qualcomm (QCOM) at Buy; The Dominator
-
Cantor Fitzgerald Starts Fluidigm Corporation (FLDM) at Buy; Taking on The Competition, One Cell At a Time
-
Cantor Fitzgerald Starts Accelrys (ACCL) at Buy; Scientific R&D Enhanced with Software
-
Cantor Fitzgerald Starts Xyratex (XRTX) at Hold; Bumpy Road Ahead
-
Cantor Fitzgerald Starts Zimmer Holdings (ZMH) at Hold; Secular Play
-
Cantor Fitzgerald Starts Stryker (SYK) at Hold; M&A Strategy Strong, But Waiting For Better Entry
-
Cantor Fitzgerald Cuts Rating and Price Target Ventrus Biosciences (VTUS); Phase III Trial Misses; New Exit Strategy Potential Sale
-
Cantor Fitzgerald Maintains a 'Buy' on Celgene (CELG); Cutting Numbers After European Application Withdrawn
-
Cantor Fitzgerald Starts Health Net (HNT) at Hold; Several Drivers Into 2013, But...
-
Cantor Fitzgerald Starts Aetna (AET) at Hold; Concentration in Lumpy National Accounts Market
-
Cantor Fitzgerald Starts WellPoint (WLP) at Hold; Business Mixed, Waiting on Better Numbers
-
Cantor Fitzgerald Starts Whole Foods Market (WFM) at Buy; Everything Just Looks Right
-
Cantor Fitzgerald Starts UnitedHealth Group (UNH) at Buy; Expecting The Best EPS Growth in 2012-13
-
Cantor Fitzgerald Starts Humana (HUM) at Buy; Medicare Is A Large Opportunity
-
Cantor Fitzgerald Upgrades China Telecom (CHA) to Hold; Priced Right
-
Cantor Fitzgerald Starts Immunogen Inc. (IMGN) at Hold, $15 Target
-
Q1 Preview: Analysts Moderate on Kroger (KR) Into Results; Fuel, Inflation are Headwinds
-
Cantor Fitzgerald Reiterates a 'Buy' on Microsemi (MSCC); Confidence Bolstered After Meeting with Management
-
Cantor Fitzgerald Downgrades Centene (CNC) to Hold; Shortfall Is A Big Psychological Blow To Medicaid Names
-
Notable Analyst Rating Changes 06/11: (EMC) (PGN) (SKX) Upgraded; (AKS) (PGR) (AEM) Downgraded
-
Cantor Fitzgerald Upgrades Brocade (BRCD) to Buy; Improving Balance Sheet & Market Share Gains
-
Cantor Fitzgerald Upgrades EMC (EMC) to Buy; Predictable, High Quality Recurring Revenue
-
Cantor Fitzgerald Upgrades NetApp (NTAP) to Buy; Compelling Risk Reward After Reset

